Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Int J Mol Sci ; 24(22)2023 Nov 17.
Article in English | MEDLINE | ID: mdl-38003658

ABSTRACT

Osteoarthritis (OA) is a complex disease of whole joints with progressive cartilage matrix degradation and chondrocyte transformation. The inflammatory features of OA are reflected in increased synovial levels of IL-1ß, IL-6 and VEGF, higher levels of TLR-4 binding plasma proteins and increased expression of IL-15, IL-18, IL-10 and Cox2, in cartilage. Chondrocytes in OA undergo hypertrophic and senescent transition; in these states, the expression of Sox-9, Acan and Col2a1 is suppressed, whereas the expression of RunX2, HIF-2α and MMP-13 is significantly increased. NF-kB, which triggers many pro-inflammatory cytokines, works with BMP, Wnt and HIF-2α to link hypertrophy and inflammation. Altered carbohydrate metabolism and the upregulation of GLUT-1 contribute to the formation of end-glycation products that trigger inflammation via the RAGE pathway. In addition, a glycolytic shift, increased rates of oxidative phosphorylation and mitochondrial dysfunction generate reactive oxygen species with deleterious effects. An important surveyor mechanism, the YAP/TAZ signaling system, controls chondrocyte differentiation, inhibits ageing by protecting the nuclear envelope and suppressing NF-kB, MMP-13 and aggrecanases. The inflammatory microenvironment and synthesis of key matrix components are also controlled by SIRT1 and mTORc. Senescent chondrocytes represent the functional end stage of hypertrophic differentiation and characteristically upregulate p16 and p21, but also a variety of inflammatory cytokines, chemokines and metalloproteinases, developing the senescence-associated secretory phenotype. Senolysis with dendrobin, miR29b-5p and other agents has been shown to be efficient under experimental conditions, and appears to be a promising tool for the treatment of OA, as it restores COL2A1 and aggrecan synthesis, suppressing NF-kB and destructive metalloproteinases.


Subject(s)
Cartilage, Articular , Osteoarthritis , Humans , Chondrocytes/metabolism , Matrix Metalloproteinase 13/metabolism , NF-kappa B/metabolism , Osteoarthritis/genetics , Osteoarthritis/metabolism , Hypertrophy/metabolism , Inflammation/metabolism , Interleukin-1beta/metabolism , Basic Helix-Loop-Helix Transcription Factors/metabolism , Cartilage, Articular/metabolism
2.
Orv Hetil ; 157(21): 836-9, 2016 May 22.
Article in Hungarian | MEDLINE | ID: mdl-27177791

ABSTRACT

Osteochondritis ischiopubica or van Neck-Odelberg disease is characterized by atypical ossification of the ischiopubic synchondrosis. Clinical symptoms are usually pain, limping and limited range of motion of the hip joint. Radiologic images may be confused with the possibility of fracture, tumor or inflammation. In some cases it may be difficult to set up the accurate diagnosis, and during the diagnostic process it is essential that van Neck-Odelberg disease should be considered. In this paper the authors draw attention to this rare disorder and they present the history of two patients who posed diagnostic difficulties.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Bed Rest , Bone Regeneration , Osteochondrosis/diagnosis , Osteochondrosis/therapy , Pain/etiology , Adolescent , Biomarkers/blood , Bone Remodeling , Child , Diagnosis, Differential , Female , Fibrosis/diagnosis , Humans , Ischium/pathology , Ischium/physiopathology , Magnetic Resonance Imaging , Male , Necrosis/diagnosis , Osteochondritis/diagnosis , Osteochondritis/therapy , Osteochondrosis/complications , Osteochondrosis/pathology , Osteochondrosis/physiopathology , Pubic Bone/pathology , Pubic Bone/physiopathology , Rare Diseases/diagnosis , Rare Diseases/therapy , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...